ORAVERSE

This brand name is authorized in United States. It is also authorized in Canada, France.

Active ingredients

The drug ORAVERSE contains one active pharmaceutical ingredient (API):

1	Phentolamine UNII Y7543E5K9T - PHENTOLAMINE MESYLATE
	Phentolamine is a competitive non-selective α1- and α2-adrenergic receptor blocker of relatively short duration of action. It causes vasodilatation and a fall in blood pressure resulting from the blockade of both post-junctional vascular α1- and α2-adrenoceptors. It also antagonises the vasoconstrictor response to noradrenaline and adrenaline infusions.
	Read more about Phentolamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ORAVERSE Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AB36	Phentolamine	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB36

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02421666
FR	Base de données publique des médicaments	68844504
US	FDA, National Drug Code	0362-0101